Old Web
English
Sign In
Acemap
>
authorDetail
>
Masahiro Shimamura
Masahiro Shimamura
Toray Industries
Medicine
Oral administration
Internal medicine
Pharmacokinetics
Urology
4
Papers
44
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The Pharmacokinetics of Beraprost Sodium Following Single Oral Administration to Subjects With Impaired Kidney Function
2017
The Journal of Clinical Pharmacology
Masahiro Shimamura
Jun Miyakawa
Masaaki Doi
Kiyonobu Okada
Hajimu Kurumatani
Yoshitaka Mori
Keiyu Oshida
Ikumi Nakajo
Keishi Oikawa
Fumihiko Ushigome
Aiji Miyashita
Masanao Isono
Yohei Miyamoto
Show All
Source
Cite
Save
Citations (7)
Identification of Transporters Involved in Beraprost Sodium Transport In Vitro
2017
European Journal of Drug Metabolism and Pharmacokinetics
Keiyu Oshida
Masahiro Shimamura
Kazuhiro Seya
Akihiro Ando
Yohei Miyamoto
Show All
Source
Cite
Save
Citations (5)
Nalfurafine hydrochloride for refractory pruritus in peritoneal dialysis patients: a phase III, multi-institutional, non-controlled, open-label trial
2017
Renal Replacement Therapy
Hidetomo Nakamoto
Takanori Oh
Masahiro Shimamura
Eiji Iida
Sadanobu Moritake
Show All
Source
Cite
Save
Citations (3)
(3R)-3-amino-4-(2,4,5-trifluorophenyl)-N-{4-[6-(2-methoxyethoxy)benzothiazol-2-yl]tetrahydropyran-4-yl}butanamide as a potent dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
2008
Bioorganic & Medicinal Chemistry Letters
Aiko Nitta
Hideaki Fujii
Satoshi Sakami
Yutaka Nishimura
Tomofumi Ohyama
Mikiya Satoh
Junko Nakaki
Shiho Satoh
Chifumi Inada
Hideki Kozono
Hiroki Kumagai
Masahiro Shimamura
Tominaga Fukazawa
Hideki Kawai
Show All
Source
Cite
Save
Citations (29)
1